| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2249.2004.02587.X |
| P698 | PubMed publication ID | 15373920 |
| P50 | author | Michael Gurevich | Q41576590 |
| P2093 | author name string | A Achiron | |
| M Mandel | |||
| R Pauzner | |||
| N Kaminski | |||
| P2860 | cites work | Cloning, characterization, and mapping of human homolog of mouse T-cell death-associated gene | Q24313012 |
| BTG1, a member of a new family of antiproliferative genes | Q24338576 | ||
| CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes | Q24338598 | ||
| Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection | Q27860727 | ||
| Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 | Q28208042 | ||
| Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 | ||
| The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis | Q28591104 | ||
| Epidemiology and estimated population burden of selected autoimmune diseases in the United States | Q33500191 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| The proteasome activator 11 S REG (PA28) and class I antigen presentation | Q33796158 | ||
| Autoimmune disease: why and where it occurs. | Q34323087 | ||
| CD24 is a genetic modifier for risk and progression of multiple sclerosis. | Q34390318 | ||
| Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview | Q34417187 | ||
| Pathways of apoptosis in lymphocyte development, homeostasis, and disease | Q34619802 | ||
| Practical approaches to analyzing results of microarray experiments | Q34768927 | ||
| Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus | Q35069509 | ||
| A two-step hypothesis for the appearance of autoimmune disease | Q35160056 | ||
| From DNA damage to G2 arrest: the many roles of topoisomerase II | Q35573690 | ||
| CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes | Q36380952 | ||
| Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity | Q40528528 | ||
| Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination | Q40831654 | ||
| Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression | Q41155094 | ||
| Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis | Q47909090 | ||
| Migration of multiple sclerosis lymphocytes through brain endothelium | Q48664436 | ||
| Control of homeostasis of CD8+ memory T cells by opposing cytokines. | Q52027383 | ||
| Tissue classification with gene expression profiles. | Q52926963 | ||
| The Interferon Inducible Autoantigen, IFI 16: Localization to the Nucleolus and Identification of a DNA-Binding Domain | Q57272617 | ||
| Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter | Q58211802 | ||
| Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus | Q71659769 | ||
| CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity | Q71755859 | ||
| Quantitative genetic variation in CD19 expression correlates with autoimmunity | Q73209385 | ||
| Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease | Q73802538 | ||
| IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis | Q73824669 | ||
| Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist | Q73886907 | ||
| Cutting edge: molecular portrait of human autoimmune disease | Q74334835 | ||
| Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus | Q77723474 | ||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| multiple sclerosis | Q8277 | ||
| P304 | page(s) | 164-170 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus | |
| P478 | volume | 138 |
| Q79894728 | A subtype of multiple sclerosis defined by an activated immune defense program |
| Q37208233 | Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients |
| Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
| Q24794318 | Can blood gene expression predict which patients with multiple sclerosis will respond to interferon? |
| Q42499339 | Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells |
| Q34246016 | Circulating microRNAs involved in multiple sclerosis |
| Q38103194 | Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases |
| Q44185075 | Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases |
| Q22306446 | Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity |
| Q30251723 | DNA-damaging autoantibodies and cancer: the lupus butterfly theory |
| Q42362971 | Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4+ T cells in systemic lupus erythematosus |
| Q42410966 | Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes |
| Q46107042 | Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility |
| Q33302909 | Gene expression signature in peripheral blood detects thoracic aortic aneurysm |
| Q35689488 | Genetic Variants of IκB Kinase β (IKBKB) and Polymerase β (POLB) Were Not Associated with Systemic Lupus Erythematosus Risk in a Chinese Han Population |
| Q35082379 | Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus |
| Q86117481 | Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation |
| Q36283450 | Heat shock protein 70: roles in multiple sclerosis |
| Q58572607 | Human and Murine Evidence for Mechanisms Driving Autoimmune Photosensitivity |
| Q37323719 | Hypothesis: sarcoidosis is a STAT1-mediated disease |
| Q54241747 | Integrative analysis of Multiple Sclerosis using a systems biology approach. |
| Q38549867 | Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus |
| Q24684208 | Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis |
| Q36162191 | Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells |
| Q48135121 | Neurological manifestations of connective tissue diseases mimicking multiple sclerosis. |
| Q97521645 | RNA-Binding Protein ZFP36L2 Downregulates Helios Expression and Suppresses the Function of Regulatory T Cells |
| Q37220552 | Scleroderma gene expression and pathway signatures |
| Q28744024 | Systematic review of genome-wide expression studies in multiple sclerosis |
| Q33644106 | Systemic lupus erythematosus diagnostics in the 'omics' era |
| Q53317057 | The NBS1 genetic polymorphisms and the risk of the systemic lupus erythematosus in Taiwanese patients. |
| Q36856159 | Variation within DNA repair pathway genes and risk of multiple sclerosis |
| Q53286384 | [DNA microarray technology: principles and applications to the study of neurological disorders] |
| Q52920821 | [Expression analyses for rheumatoid arthritis]. |
Search more.